These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2780621)

  • 1. Effect of bidentate nitrogen heterocycles on dopamine beta-hydroxylase activity in vitro.
    Waterbury LD; Serrato C; Martinez GR
    Proc West Pharmacol Soc; 1989; 32():9-13. PubMed ID: 2780621
    [No Abstract]   [Full Text] [Related]  

  • 2. Analogues of fusaric (5-butylpicolinic) acid as potent inhibitors of dopamine -hydroxylase.
    Hidaka H; Asano T; Takemoto N
    Mol Pharmacol; 1973 Mar; 9(2):172-7. PubMed ID: 4197141
    [No Abstract]   [Full Text] [Related]  

  • 3. Unsaturated heterocyclic amines as potent time-dependent inhibitors of dopamine beta-hydroxylase.
    Bargar TM; Broersma RJ; Creemer LC; McCarthy JR; Hornsperger JM; Palfreyman MG; Wagner J; Jung MJ
    J Med Chem; 1986 Mar; 29(3):315-7. PubMed ID: 3950911
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase.
    Palatini P; Dabbeni-Sala F; Finotti P
    Biochem Int; 1984 Dec; 9(6):675-82. PubMed ID: 6525203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of dopamine beta-monooxygenase by histidine.
    Izumi H; Hayakari M; Kondo Y; Takemoto T
    Hoppe Seylers Z Physiol Chem; 1975 Nov; 356(11):1831-3. PubMed ID: 1205455
    [No Abstract]   [Full Text] [Related]  

  • 6. The enzyme-bound copper of dopamine beta-monooxygenase. Reaction with copper chelators, preparation of the apoprotein, and kinetics of the reconstitution by added copper.
    Skotland T; Ljones T
    Eur J Biochem; 1979 Feb; 94(1):145-51. PubMed ID: 108101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the antitumor activity of new epoxide derivatives. Part II: N-glycidylated oxo-nitrogen heterocycles.
    Fischer H; Möller H; Budnowski M; Atassi G; Dumont P; Venditti J; Yoder OC
    Arzneimittelforschung; 1984; 34(6):663-8. PubMed ID: 6541486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dopamine beta-hydrolase].
    Nagatsu T
    Tanpakushitsu Kakusan Koso; 1983 Jul; (26 Suppl):287-98. PubMed ID: 6361870
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of 2,4,6-trisubstituted pyrimidine and triazine heterocycles as antileishmanial agents.
    Sunduru N; Agarwal A; Katiyar SB; Nishi ; Goyal N; Gupta S; Chauhan PM
    Bioorg Med Chem; 2006 Dec; 14(23):7706-15. PubMed ID: 16945542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-beta-hydroxylase.
    Rosenberg RC; Lovenberg W
    Essays Neurochem Neuropharmacol; 1980; 4():163-209. PubMed ID: 6248338
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of 1-phenyl-3-(2-thiazolyl)-2-thiourea, a dopamine beta-hydroxylase inhibitor on morphine analgesia, tolerance and physical dependence.
    Bhargava HN; Way EL
    J Pharmacol Exp Ther; 1974 Jul; 190(1):165-75. PubMed ID: 4858783
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo inhibition of serum dopamine-beta-hydroxylase by CaNa2 EDTA injection.
    De Paris P; Caroldi S
    Hum Exp Toxicol; 1994 Apr; 13(4):253-6. PubMed ID: 8204310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible inhibition of dopamine-beta-hydroxylase by cysteine.
    Izumi H; Oyama H; Hayakari M; Ozawa H
    Biochem Pharmacol; 1976 Feb; 25(4):488-9. PubMed ID: 938576
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of dopamine beta-hydroxylase by bidentate chelating agents.
    Townes S; Titone C; Rosenberg RC
    Biochim Biophys Acta; 1990 Feb; 1037(2):240-7. PubMed ID: 2306475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domino cu-catalyzed C--N coupling/hydroamidation: a highly efficient synthesis of nitrogen heterocycles.
    Martín R; Rodríguez Rivero M; Buchwald SL
    Angew Chem Int Ed Engl; 2006 Oct; 45(42):7079-82. PubMed ID: 17009380
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthetic approaches to some new sulfur-containing heterocycles of anticipated immunosuppressive activity.
    Girges MM; Hanna MA; Ayyad SN
    Boll Chim Farm; 1995 Apr; 134(4):204-8. PubMed ID: 7605605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple copper salt-catalyzed N-arylation of nitrogen-containing heterocycles with aryl and heteroaryl halides.
    Zhu L; Guo P; Li G; Lan J; Xie R; You J
    J Org Chem; 2007 Oct; 72(22):8535-8. PubMed ID: 17902694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effects of protein-like substance(s) on dopamine beta-Hydroxylase (author's transl)].
    Oyama H; Izumi H; Ozawa H
    Yakugaku Zasshi; 1975 May; 95(5):621-2. PubMed ID: 807701
    [No Abstract]   [Full Text] [Related]  

  • 19. A new copper-catalyzed [3 + 2] cycloaddition: enantioselective coupling of terminal alkynes with azomethine imines to generate five-membered nitrogen heterocycles.
    Shintani R; Fu GC
    J Am Chem Soc; 2003 Sep; 125(36):10778-9. PubMed ID: 12952444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase.
    Stanley WC; Li B; Bonhaus DW; Johnson LG; Lee K; Porter S; Walker K; Martinez G; Eglen RM; Whiting RL; Hegde SS
    Br J Pharmacol; 1997 Aug; 121(8):1803-9. PubMed ID: 9283721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.